Cloning of a new Kunitz-type protease inhibitor with a putative transmembrane domain overexpressed in pancreatic cancer
about
Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironmentDistribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissuesGenomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genesTissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1Expression profiling of gastric adenocarcinoma using cDNA array.Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.Strategies for the detection of disease genes in pancreatic cancer.Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration.Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cellsHAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian womenPotent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.The basal chorionic trophoblast cell layer: An emerging coordinator of placenta development.Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitroUpregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa.Use of representational difference analysis to study the effect of TGFB on the expression profile of a pancreatic cancer cell line.Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers.The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer.Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma.Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells.Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas.
P2860
Q28140022-86032253-1D94-4070-891E-1863F873F306Q28142489-8B2649F5-654D-474B-BD68-96DF0FAF48C5Q28145050-9D91343B-2E99-4065-8CA1-2E4C41361EE8Q28180175-F5CE5E72-CADC-4330-9F5C-361A2B03A722Q30307391-F2634949-AA33-4243-82F8-DB5DA635870CQ33654192-A3DC3E4D-5500-41FE-82B7-0930B3D9A11DQ33692996-59DE7164-2E6D-41F6-975B-BC986A99C29BQ34592412-95366416-8CB1-46F3-BD9F-90DF418220B1Q35022070-B4ADA09F-4993-454B-9114-80204C3CC62DQ35041020-DED3E382-776D-4AF0-B519-E3334CDDBA6AQ35145031-684BD205-4AF0-4ABD-8893-1056E7A82099Q35807962-D25F9D88-EB4B-4378-803D-243691089F49Q36944800-C8927092-DAB0-4CAC-AAEB-2103E64C62B1Q37197314-BA2A7075-FB78-4957-884C-EE1A68612810Q38700458-A7A0390B-C1CD-4BFC-A38A-8F625AC3F595Q40581709-5C76BCE5-39B7-4FE0-8B4C-D4F1661C0C07Q40887379-F8931F13-C049-4B89-8A96-51E4A7AF6763Q40936571-1F0BA145-AB7A-442E-98F6-9D7B2BA8C91BQ52676719-2A7BC2AB-C3CE-4069-B2A1-4AEDECAB0D75Q54415251-8FE3D004-D863-46CB-9E44-A51FD1C67ED3Q55043279-8A7D91CA-C59F-45E1-B945-A248457723F7Q55343941-E6DDE182-5320-4073-AA7C-4F5002A9120AQ55456643-DB175B2D-0E92-4159-9C29-A06ADFFB0901
P2860
Cloning of a new Kunitz-type protease inhibitor with a putative transmembrane domain overexpressed in pancreatic cancer
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@ast
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@en
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@en-gb
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@nl
type
label
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@ast
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@en
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@en-gb
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@nl
prefLabel
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@ast
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@en
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@en-gb
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@nl
P2093
P1476
Cloning of a new Kunitz-type p ...... expressed in pancreatic cancer
@en
P2093
C Wallrapp
F Müller-Pillasch
P356
10.1016/S0167-4781(97)00129-2
P407
P577
1998-01-07T00:00:00Z